- ￥1500.90 - 36000.90
- 阿拉丁
- 上海
- K648988
- 2026年01月06日
企业认证
相关产品推荐更多 >
异薰草素，491-31-6，≥97%，阿拉丁
￥339.90![(2S)-2-benzyl-3-{[(2S)-1-[(2S)-2-acetamido-4-methylpentanoyl]pyrrolidin-2-yl](hydroxy)phosphoryl}propanoic acid，Moligand™，阿拉丁](https://img1.dxycdn.com/p/s14/2024/0619/722/0483842343985733081.jpg!wh200)
(2S)-2-benzyl-3-{[(2S)-1-[(2S)-2-acetamido-4-methylpentanoyl]pyrrolidin-2-yl](hydroxy)phosphoryl}propanoic acid，Moligand™，阿拉丁
￥3999.90
WAY-324979，221120-57-6，10mM in DMSO，阿拉丁
￥720.90
Daclatasvir (BMS-790052)，1009119-64-5，Moligand™, ≥98%，阿拉丁
￥64.90
SM-164 Hydrochloride，10mM in Water，阿拉丁
￥7642.90
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20°C储存
- 英文名：
K-Ras G12C-IN-1
- 库存：
期货
- 供应商：
上海阿拉丁生化科技股份有限公司
- CAS号：
1629265-17-3
- 规格：
K648988-5mg/K648988-50mg/K648988-1mg/K648988-10mg/K648988-100mg
| 规格： | K648988-5mg | 产品价格： | ￥3500.9 |
|---|---|---|---|
| 规格： | K648988-50mg | 产品价格： | ￥21000.9 |
| 规格： | K648988-1mg | 产品价格： | ￥1500.9 |
| 规格： | K648988-10mg | 产品价格： | ￥5000.9 |
| 规格： | K648988-100mg | 产品价格： | ￥36000.9 |
英文名：K-Ras G12C-IN-1
纯度或规格：≥98%
SPU：K648988
CAS：1629265-17-3
存储温度：-20°C储存
运输条件：超低温运输
查看阿拉丁官网此产品相关对应页面：
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Detection of K-ras Mutations by a Microelectronic DNA Chip
. These potential molecular tumor markers are essential not only for the diagnosis, prognosis, or the follow-up of the disease but also for the management of therapy (1 ,2 ). Particularly, the K-ras protooncogene is altered, by point mutations within codons
A Novel Method for the Production of Fully Modified K-Ras 4B
post-translationally modified proteins in bacterial expression systems is often problematic. Here, we describe a novel recombinant approach to prepare human K-Ras 4B, a protein that is post-translationally farnesylated
Analysis of K-RAS and P53 Mutations in Sputum Samples
Mutations in the P53 tumor suppressor gene and the K-RAS oncogene have frequently been found in sputum and bronchoalveolar lavage (BAL) samples of lung cancer patients, and also in samples from patients prior to presenting clinical symptoms
技术资料暂无技术资料 索取技术资料
